论文部分内容阅读
慢性肺源性心脏病简称慢性肺心病,是呼吸系统的常见病和多发病,其发病机制很多,但先决条件是肺功能和结构的不可逆性改变,发生反复的气道感染和低氧血症。慢性肺心病的主要病因是慢性阻塞性肺疾病(COPD),占80%~90%,由于患者肺功能进行性减退,严重影响患者的劳动能力和生活质量。感染是促使和加重肺功能减退的主要原因。研究发现慢性肺心病患者免疫功能明显低下,这是患者反复发生感染的原因。因此,在慢性肺心病患者的治疗过程中,增加机体免疫功能的治疗,对减少呼吸道反复感染和延缓肺功能的进行性减退有重要意义。
Chronic pulmonary heart disease referred to as chronic pulmonary heart disease, is a common and frequently-occurring disease of the respiratory system, the pathogenesis of many, but the prerequisite is the irreversible changes in lung function and structure, recurrent airway infections and hypoxemia . Chronic pulmonary heart disease is the main cause of chronic obstructive pulmonary disease (COPD), accounting for 80% to 90%, due to the patient’s lung function progressive decline, seriously affecting the patient’s ability to work and quality of life. Infection is to promote and aggravate the main reason for hypogonadism. The study found that patients with chronic cor pulmonale were significantly lower immune function, which is the cause of recurrent infections in patients. Therefore, in the treatment of patients with chronic cor pulmonale, increasing the immune function of the body to treat, reduce respiratory recurrent infection and delay the progressive decline of pulmonary function is important.